Formulation development of modified release dosage form for improving clinical outcomes

dc.contributor.guide	Gowramma, B
dc.coverage.spatial	Pharmacy
dc.creator.researcher	M, Senthilkumar
dc.date.accessioned	2022-04-01T10:24:27Z
dc.date.available	2022-04-01T10:24:27Z
dc.date.awarded	2022
dc.date.completed	2021
dc.date.registered	2018
dc.description.abstract	available
dc.description.note	quotsummary p 77, References 78-82 p quot
dc.format.accompanyingmaterial	CD
dc.format.dimensions	3
dc.format.extent	i-vii, 1-82 p
dc.identifier.uri	http://hdl.handle.net/10603/371543
dc.language	English
dc.publisher.institution	Colleges of Pharmacy
dc.publisher.place	Mysore
dc.publisher.university	JSS Academy of Higher Education and Research
dc.relation	86
dc.rights	university
dc.source.university	University
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.subject.keyword	Zaltoprofen, Invivo, and Invitro studies, sustained release formulation, immediate-release formulation, rabbit plasma, liquid-liquid extraction, Tablet.
dc.title	Formulation development of modified release dosage form for improving clinical outcomes
dc.title.alternative
dc.type.degree	Ph.D.